Trial of Psilocybin vs Escitalopram for Depression
July 27, 2021 DOI: 10.64239/pi-qt2903 (opens in new tab)
Summary
AI-generated from the abstractA mood disorder study compared escitalopram against a placebo, an unusual design. The results showed the drug was not better than placebo, but equivalent.
Study at a glance
| Characteristics | Randomized controlled trial |
|---|---|
| Intervention | Escitalopram |
| Key finding | Escitalopram was not better than placebo, but equivalent. |
Abstract
A mood disorder study published in the New England Journal of Medicine is a bullet unto itself. Use of escitalopram, not a placebo, for the comparison group—another rarity! And the results? Well, not better, but equivalent. Here comes big pharmaceutical company money.